Twist Bioscience Launches Portfolio of RNA Sequencing Tools

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon p...

May 23, 2023 | Tuesday | News
Rakuten Medical Initiates Global Phase 3 Trial of Alluminox™ Treatment for Head and Neck Cancer in India

The Company has been granted permission from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global, pivotal Phase 3 clinical...

May 23, 2023 | Tuesday | News
CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech

CSafe's custom thermal shipper for Krystal maintains -20°C throughout the product journey to help ensure that doses of Vyjuvek reach clinicians and pat...

May 22, 2023 | Monday | News
Dasa Expands Its Capabilities with SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, celebrates today with longstanding partner, Da...

May 16, 2023 | Tuesday | News
GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care

GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magn...

May 15, 2023 | Monday | News
Aligos Therapeutics partners with Xiamen Amoytop for liver disease treatment using oligonucleotide platform

Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liv...

May 15, 2023 | Monday | News
UCB and Ariceum Therapeutics Partner for Immune-Related Disease and Cancer Treatment Research

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum's discovery of t...

May 11, 2023 | Thursday | News
Bayer and Bicycle Therapeutics Partner for Targeted Radionuclide Therapies in Oncology

Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...

May 11, 2023 | Thursday | News
China NMPA Approves TYVYT® Combo for EGFR-mutated NSCLC Patients Who Progressed After EGFR-TKI Therapy

This is the seventh NMPA-approved indication of TYVYT® (sintilimab injection). The first six indications of TYVYT® (sintilimab injection) are inclu...

May 10, 2023 | Wednesday | News
Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

Under the terms of the agreement, Acorda will receive an up-front payment of $2.5 million, a near term milestone payment of up to $6 million, $3 million up...

May 09, 2023 | Tuesday | News
Soligenix Reports Positive Results for HyBryte™ Compatibility Study in Cutaneous T-Cell Lymphoma Treatment

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre...

May 05, 2023 | Friday | News
Amphista Therapeutics Achieves First Discovery Milestone in Collaboration with Bristol Myers Squibb

Nicola Thompson, CEO of Amphista, said, "We are absolutely delighted with the progress and success of our collaboration with BMS. Our ability to deliver ou...

May 05, 2023 | Friday | News
Sapience Therapeutics Awarded $2M Grant to Evaluate Therapeutic Potential of ST316, a First-in-Class Antagonist.

The proposed non-clinical studies will investigate pharmacodynamic biomarkers for ST316, a first-in-class β-catenin antagonist, and evaluate the impac...

May 05, 2023 | Friday | News
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

OnKai, a US-based technology company, combines public healthcare and medical innovation experience with complex process digitalization, design thinking, an...

May 05, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close